FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Their state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. They are authorised under EMA for theproduction of gene therapy products for clinical and commercial supply.

Biotechnology

Life Sciences

Research

FinVector Oy

FinVector Oy's headquarters in Kuopio, Finland

Description

People (3)

Anna-Maria Tuokko

Elisa Kajander

Riikka Kalliokoski

Jobs